Stock detail
Beam Therapeutics (BEAM) stock price, chart, and key data
View Beam Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Beam Therapeutics
BEAM · XNAS
$24.16
-0.86%
-$0.21
Key metrics
52-week range
$2.00 - $18.00
Close price
$24.37
Market cap
$2.6B
P/E ratio
-29.71
Beta
3.29
About the company
Beam Therapeutics Inc
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$52.30
10
Buy
/ 11
Recent calls
09/09/2026
Wedbush
Unknown Analyst
Buy · Price target $65.00
09/09/2026
JonesTrading
Boris Peaker
Buy · Price target $35.00
09/09/2026
Canaccord Genuity
Whitney Ijem
Buy · Price target $78.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
No holder data is available for this category yet.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app